Topaloglu R, Bakkaloglu A, Slingsby J H, Mihatsch M J, Pascual M, Norsworthy P, Morley B J, Saatci U, Schifferli J A, Walport M J
Department of Pediatric Nephrology and Rheumatology, Hacettepe University, Ankara, Turkey.
Kidney Int. 1996 Aug;50(2):635-42. doi: 10.1038/ki.1996.359.
Two siblings (case 1 and case 2) with homozygous C1q deficiency are described. Both presented with a photosensitive rash, and during follow-up case one developed SLE with nephrotic range proteinuria. Case 2 had microscopic hematuria with a past history of macroscopic hematuria. Renal biopsies revealed mesangioproliferative glomerulonephritis in case 1 and IgA nephropathy in case 2, a new finding in association with C1q deficiency. Since the classical pathway of complement plays a role in the development of antibody responses, the family was also evaluated for the immune response to hepatitis B vaccine. Antibody response to hepatitis B vaccine was normal in both affected members and the rest of the family. The A-, B- and C- chain genes of C1q were amplified by PCR and directly sequenced. A homozygous C to T point mutation was identified in genomic DNA isolated from the patients at codon 186 in the A chain that resulted in a premature stop codon. This mutation was present in both parents and both unaffected sibs in the heterozygous state. This mutation was identical to that previously described in a Slovakian family with C1q deficiency. Because of this finding, a series of 92 genomic DNA samples was screened from ethnically distinct patient groups with SLE to test the hypothesis that this mutation of C1q may be a widespread disease susceptibility gene. No further examples of this mutation were found.
本文描述了两名患有纯合子C1q缺乏症的兄弟姐妹(病例1和病例2)。两人均出现光敏性皮疹,在随访期间,病例1发展为伴有肾病范围蛋白尿的系统性红斑狼疮。病例2有镜下血尿,既往有肉眼血尿病史。肾活检显示病例1为系膜增生性肾小球肾炎,病例2为IgA肾病,这是与C1q缺乏相关的新发现。由于补体经典途径在抗体反应的发展中起作用,因此还对该家族进行了乙肝疫苗免疫反应评估。两名受影响成员和家族其他成员对乙肝疫苗的抗体反应均正常。通过PCR扩增C1q的A、B和C链基因并直接测序。在从患者分离的基因组DNA中,在A链第186密码子处鉴定出一个纯合的C到T点突变,该突变导致提前终止密码子。这种突变在父母和两名未受影响的兄弟姐妹中均以杂合状态存在。该突变与先前在一个患有C1q缺乏症的斯洛伐克家族中描述的突变相同。基于这一发现,从不同种族的系统性红斑狼疮患者群体中筛选了92份基因组DNA样本,以检验C1q的这种突变可能是一种广泛存在的疾病易感基因这一假设。未发现该突变的其他实例。